Desperately looking for the right target in osteoarthritis: the anti-IL-1 strategy

Blocking IL-1 in patients with knee osteoarthritis is an attractive strategy. Cohen and colleagues report a randomised, placebo-controlled, multiple-dose trial using a monoclonal antibody blocking IL-1 type 1 receptor. They failed to show any positive results in terms of evolution of pain for up to...

Descripción completa

Detalles Bibliográficos
Autores principales: Chevalier, Xavier, Conrozier, Thierry, Richette, Pascal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3239369/
https://www.ncbi.nlm.nih.gov/pubmed/21888686
http://dx.doi.org/10.1186/ar3436

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3239369/
https://www.ncbi.nlm.nih.gov/pubmed/21888686
http://dx.doi.org/10.1186/ar3436

Ejemplares similares